Sonnet Biotherapeutics Receives Shareholder Approval to Merge with Hyperliquid Strategies

By: theblockbeats.news|2025/12/02 14:45:54
Compartilhar
copy

BlockBeats News, December 2nd, According to market sources, Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies.

Previously reported, Hyperliquid Strategies plans to raise up to $1 billion, intended to be used to purchase HYPE, etc.

Populares

Últimas notícias sobre cripto

Leia mais